Antiretrovirals (ARV) are medications used to prevent or treat HIV infection by inhibiting viral replication.
ARVs are studied individually and in combination regimens to optimize efficacy and minimize resistance. Research includes pharmacokinetic assessments, safety monitoring, and interaction analysis. Regulatory oversight ensures appropriate risk mitigation strategies. Continued evaluation supports durable viral suppression and treatment innovation.